Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats.

被引：0
|
作者：
Tada, S
Nakamuta, M
Tsuruta, S
Ohta, S
Fukutomi, M
Kuniyoshi, M
Enjoji, M
Nawata, H
机构：
[1] Fukuoka City Hosp, Fukuoka, Japan
[2] Kyushu Univ, Dept Med & Bioregulat Sci, Grad Sch Med Sci, Fukuoka 812, Japan
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
836
引用
收藏
页码：381A / 381A
页数：1
相关论文
共 50 条
  • [1] Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats
    Tsuruta, S
    Nakamuta, M
    Enjoji, M
    Kotoh, K
    Hiasa, K
    Egashira, K
    Nawata, H
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2004, 14 (05) : 837 - 842
  • [2] Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice
    Inoshima, I
    Kuwano, K
    Hamada, N
    Hagimoto, N
    Yoshimi, M
    Maeyama, T
    Takeshita, A
    Kitamoto, S
    Egashira, K
    Hara, N
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2004, 286 (05) : L1038 - L1044
  • [3] Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats
    Ikeda, Y
    Yonemitsu, Y
    Kataoka, C
    Kitamoto, S
    Yamaoka, T
    Nishida, KI
    Takeshita, A
    Egashira, K
    Sueishi, K
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (05): : H2021 - H2028
  • [4] Anti-monocyte chemoattractant protein-1 gene therapy in collagen antibody-induced arthritis
    Belvoncikova, P.
    Borbelyova, V.
    Gromova, B.
    Schuh, B.
    Gardlik, R.
    Celec, P.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A166 - A166
  • [5] Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats
    Kumai, Y
    Ooboshi, H
    Takada, J
    Kamouchi, M
    Kitazono, T
    Egashira, T
    Ibayashi, S
    Iida, M
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2004, 24 (12): : 1359 - 1368
  • [6] Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice
    Shimizu, S
    Nakashima, H
    Masutani, K
    Inoue, Y
    Miyake, K
    Akahoshi, M
    Tanaka, Y
    Egashira, K
    Hirakata, H
    Otsuka, T
    Harada, M
    RHEUMATOLOGY, 2004, 43 (09) : 1121 - 1128
  • [7] Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria
    Shimizu, H
    Maruyama, S
    Yuzawa, Y
    Kato, T
    Miki, Y
    Suzuki, S
    Sato, W
    Morita, Y
    Maruyama, H
    Egashira, K
    Matsuo, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (06): : 1496 - 1505
  • [8] Suppressive effects of antioxidant on dimethylnitrosamine-induced hepatic fibrosis in rats.
    Cheong, J
    Oh, T
    Ahn, BO
    Kim, W
    Lee, K
    Yoo, B
    Kim, Y
    Kim, J
    Hahm, K
    Cho, S
    HEPATOLOGY, 2002, 36 (04) : 474A - 474A
  • [9] Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 α in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy
    Göser, S
    Öttl, R
    Brodner, A
    Dengler, TJ
    Torzewski, J
    Egashira, K
    Rose, NR
    Katus, HA
    Kaya, Z
    CIRCULATION, 2005, 112 (22) : 3400 - 3407
  • [10] DETECTION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 IN HUMAN ATHEROSCLEROTIC LESIONS BY AN ANTI-MONOCYTE CHEMOATTRACTANT PROTEIN-1 MONOCLONAL-ANTIBODY
    TAKEYA, M
    YOSHIMURA, T
    LEONARD, EJ
    TAKAHASHI, K
    HUMAN PATHOLOGY, 1993, 24 (05) : 534 - 539
12345